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The BRCT domain of the S. cerevisiae checkpoint protein Rad9
mediates a Rad9–Rad9 interaction after DNA damage
Jean Soulier and Noel F. Lowndes
The Saccharomyces cerevisiae checkpoint protein Rad9
is required for transient cell-cycle arrest and
transcriptional induction of DNA-repair genes in
response to DNA damage [1]. It contains a carboxy-
terminal tandem repeat of the BRCT (BRCA1 carboxyl
terminus) motif, a motif that is also found in many
proteins involved in various aspects of DNA repair,
recombination and checkpoint control [2,3]. We
produced yeast strains expressing Rad9 in which the
BRCT domain had been deleted or which harboured
point mutations in the highly conserved aromatic
residue of each BRCT motif. Rates of survival and
checkpoint delay of the mutants after ultraviolet (UV)
irradiation were essentially equivalent to those of rad9∆
(null) cells, demonstrating that the BRCT domain is
required for Rad9 function. Rad9 hyperphosphorylation,
which occurs after DNA damage [4–6], was absent in the
BRCT mutants, as was Rad9-dependent phosphorylation
of the Rad53 protein. A two-hybrid approach identified a
specific interaction between the Rad9 BRCT domain and
itself. Biochemical analysis in vitro and in vivo
confirmed this interaction and, furthermore,
demonstrated that the Rad9 BRCT domain preferentially
interacted with the hyperphosphorylated forms of Rad9.
This interaction was suppressed by mutations of the
BRCT motifs that caused null phenotypes in vivo,
suggesting that Rad9 oligomerization is required for
Rad9 function after DNA damage.
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Results and discussion
To investigate the role of the tandem BRCT motifs of
Rad9, they were mutated as indicated in Figure 1a. A
carboxy-terminally truncated Rad9 protein (Rad9∆CT),
which lacks the BRCT domain, was expressed under the
control of a galactose-inducible (GAL) promoter in a
rad9∆ (null) yeast strain. We observed that Rad9∆CT was
substantially less able to complement survival of the
rad9∆ strain after UV irradiation than wild-type RAD9,
demonstrating that the BRCT domain is critical for Rad9
function (Figure 1b). Site-directed mutagenesis was used
to alter an aromatic residue in each BRCT motif
(Figure 1a). This residue, which is F1104 (in the single-
letter amino acid code) in the first BRCT motif of Rad9
(BRCTa) and W1280 in the second (BRCTb), has been
described as the most highly conserved residue of the
BRCT motif [2,3]. We replaced this residue with leucine
in order to maintain hydrophobicity. The mutant proteins
were expressed under the control of the GAL promoter in
rad9∆ cells. Induced levels of both wild-type and point-
mutated Rad9 were about 100-fold above the level of
endogenous Rad9, whereas the level of Rad9∆CT was
about 20-fold above (See Supplementary material pub-
lished with this article on the internet). In all cases, sur-
vival after UV irradiation was reduced relative to cells
expressing wild-type RAD9 (Figure 1b). Mutations in
BRCTb alone (rad9W) or in both BRCT motifs (rad9F+W)
mimicked rad9∆CT, demonstrating a more dramatic phe-
notype than the mutation of BRCTa alone (rad9F).
Overexpression of checkpoint genes, including RAD9, can
modify the checkpoint response [7]. We therefore pro-
duced integrative mutants in order to test the mutated
Rad9 proteins at normal levels of expression. We replaced
the 3′ end of wild-type RAD9 by targeted integration of
sequences encoding the different mutations. The rad9∆CT,
rad9W and rad9F+W strains had survival rates after UV irradi-
ation as low as rad9∆ (Figure 2a). The rad9W mutant sur-
vived slightly better than the other mutant strains. Also, the
rad9F+W strain was tested for its ability to arrest at the G2
checkpoint after UV irradiation. A deficiency in arrest at
the G2 checkpoint similar to that of the rad9∆ control was
observed (Figure 2b). Western-blot analysis of the mutant
Rad9 proteins demonstrated levels of expression equiva-
lent to wild-type Rad9, except for Rad9∆CT, which was
consistently expressed at 2–3-fold lower levels (Figure 2c).
Rad9 is normally hyperphosphorylated after DNA damage,
and this coincides with checkpoint arrest [4–6]. In contrast
to wild-type cells, none of the rad9 BRCT mutants dis-
played any hyperphosphorylation after DNA damage
(Figure 2c) or methyl methane-sulphonate (data not
shown). Although it is possible that critical phosphorylation
sites could be located within the BRCT domain of Rad9,
and therefore could be missing when this domain is
deleted, the absence of hyperphosphorylation after DNA
damage in rad9 point mutants showed that this phenome-
non was not simply due to the loss of phosphorylation sites.
Rad53 functions downstream of Rad9 in the checkpoint
pathway [8,9] and some Rad53 interacts with the hyper-
phosphorylated forms of Rad9 after DNA damage [4–6].
Western-blot analysis of the mutants demonstrated that no
Rad9-dependent phosphorylation of Rad53 occurred in the
BRCT rad9 mutants after DNA damage (Figure 2c). 
Together, these results demonstrate that the BRCT
domain of Rad9 has a critical role in the Rad9-dependent
activation of the DNA damage checkpoint pathway.
Because BRCT domains are likely to mediate
protein–protein interaction, a two-hybrid approach was
used to identify binding partners of this domain using the
complete Rad9 BRCT domain fused to the GAL4 DNA-
binding domain (BRCT–BD). Unlike the related BRCT
domain of BRCA1, the Rad9 BRCT–BD fusion protein did
not itself activate the β-galactosidase reporter gene used in
the assay. An interaction between the Rad9 BRCT–BD
and the Rad9 BRCT domain fused to the GAL4 activation
domain (BRCT–AD) was identified (Figure 3a).
BRCT–BD also interacted with full-length Rad9 fused to
the GAL4 activation domain (Rad9–AD). In contrast, the
mutated BRCTF+W–BD fusion protein failed to interact
with BRCT–AD and Rad9–AD. Using this system we also
tested other candidate proteins for interaction with the
Rad9 BRCT: the other BRCT-containing proteins of S.
cerevisiae [2,3], because interactions between BRCT
domains of different proteins have been reported [10–12];
Rad53, which has been shown to interact with Rad9 [4–6];
and Dpb11 (which also contains BRCT domains) and the
protein encoded by YBR274w, which share sequence
homology with the Schizosaccharomyces pombe Cut5/Rad4
and Chk1 checkpoint proteins, respectively, and which
both interact with Crb2, an S. pombe checkpoint protein
related to Rad9 [11]. With the exception of Rad9 itself,
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Figure 2
The effects of normal levels of expression of the BRCT-mutated Rad9
proteins on survival, the G2/M checkpoint and hyperphosphorylation
after damage. (a) Sensitivity to UV of the mutant proteins expressed at
levels equivalent to the wild-type Rad9 protein. Error bars were omitted
for clarity but consistent results were obtained from at least three
experiments. (b) G2-checkpoint phenotype analysis of the rad9F+W
mutant. Cells that arrest at the G2 checkpoint are large, budded and
with a single nucleus. Error bars have been omitted for clarity, but
standard deviations from at least three experiments were < 5% in all
cases. (c) Western-blot analysis of the Rad9 and Rad53 proteins in
non-irradiated and UV-irradiated cells. The BRCT mutants were grown
to exponential phase and either mock-treated or UV-irradiated
(50 J/m2). The resulting protein extracts were blotted and probed with
anti-Rad9 and anti-Rad53 antisera. P-Rad9 and P-Rad53 indicate the
hyperphosphorylated forms of Rad9 and the phosphorylated forms of
Rad53, respectively.
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Figure 1
The effects of overexpression of the BRCT-mutated Rad9 proteins on
survival after UV irradiation. (a) The mutated proteins are illustrated
schematically. The stars denote the F1104L and W1280L point
mutations in BRCTa and BRCTb, respectively. (b) The mutant and wild-
type (WT) proteins were expressed at a high level under the control of a
GAL promoter in a rad9∆ (null) strain and the survival of the strains after
UV irradiation was measured. Error bars were omitted for clarity but
consistent results were obtained from at least three experiments.
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however, none of these proteins interacted with Rad9
BRCT–BD (see Supplementary material).
The Rad9 BRCT–BRCT interaction was biochemically
analysed using glutathione-S-transferase (GST) fusion pro-
teins and differentially tagged Rad9 proteins. A
GST–BRCT fusion protein, but not GST–BRCTF+W,
could bind bacterially expressed T7-tagged Rad9, demon-
strating a direct BRCT–BRCT interaction (Figure 3b). The
GST–BRCT fusion protein consistently bound the hyper-
phosphorylated forms of Rad9 from extracts of wild-type,
DNA-damaged yeast cells (Figure 3c). Strikingly, it was also
able to preferentially bind a small amount of hyperphospho-
rylated Rad9 from extracts prepared from non-damaged
cells (Figure 3c). This presumably reflects residual low
levels of endogenous damage that are not normally detected
by western blot. In contrast, the GST–BRCTF+W fusion
protein failed to bind hyperphosphorylated forms of Rad9
from UV-irradiated or non-irradiated cell extracts (Figure
3c). Relative to a low background of non-specific binding of
Rad9 to GST (also seen in [5]), some of the faster-migrating
(hypophosphorylated) forms of Rad9 were also bound by
GST–BRCT and GST–BRCTF+W. When compared with
the relative amounts of hypo- and hyperphosphorylated
Rad9 present in the input extracts, this interaction appeared
to be weaker than with the hyperphosphorylated Rad9.
Moreover, this aromatic-residue-independent interaction
with hypophosphorylated Rad9 was more salt-sensitive than
the aromatic-residue-dependent interaction with hyper-
phosphorylated Rad9 (data not shown). 
These in vitro results were confirmed in vivo using diploid
strains that simultaneously expressed, at normal levels,
two differentially tagged Rad9 proteins (Figure 3d). Rad9
proteins bearing three haemagglutinin (HA) tags
(HA3–Rad9) copurified with ten-histidine (His10)-tagged
Rad9 (His10–Rad9) proteins when they were affinity puri-
fied on nickel–agarose beads. Full-length His10–Rad9
interacted with the most hyperphosphorylated forms of
HA3–Rad9 present after DNA damage with greater affin-
ity than with hypophosphorylated forms (Figure 3d, top
panel). Copurification of hyperphosphorylated HA3–Rad9
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Figure 3
Analysis of BRCT-mediated Rad9–Rad9
interaction. (a) Two-hybrid analysis of the
interaction of the Rad9 BRCT domain with
itself and with full-length Rad9. β-galactosid-
ase activity was tested on the mated strains
as indicated: BRCT–BD and BRCTF+W–BD,
the wild-type and mutated Rad9 BRCT
domains, respectively, fused to BD;
BRCT–AD and Rad9–AD, the Rad9 BRCT
and full-length Rad9, respectively, fused to
AD; p53–BD, p53 protein fused to BD;
SV40–AD, simian virus 40 (SV40) large T
antigen fused to AD; Laminin–BD, laminin
fused to BD. The lack of interaction between
laminin and any AD fusion serves as a
negative control. The positive control is the
interaction of the p53 protein with the SV40
large T antigen. (b) In vitro interaction of
bacterially expressed T7-tagged BRCT
(T7–BRCT) with GST–BRCT. Bacterial
extracts containing the T7–BRCT fusion
protein (input) were incubated with GST or
with GST-fusion proteins as shown. After
extensive washes, T7–BRCT was revealed by
T7 western blotting. The levels of the GST-
fusion proteins, determined by Coomassie-
blue staining, are shown in the bottom panel.
(c) Binding of Rad9 by GST–BRCT from wild-
type yeast extracts. Equal quantities of
proteins from UV-irradiated (60 J/m2) or mock-
treated wild-type cells were incubated with
equivalent quantities of GST or the fusion
proteins GST–BRCT or GST–BRCTF+W. The
bound forms of Rad9 (indicated on the right)
were revealed by western blotting. Input
protein extracts from wild-type cells are
shown in the left panels and the levels of the
GST-fusion proteins, determined by
Coomassie-blue staining, are shown in the
bottom panel. (d) Western blot of HA3–Rad9
after co-purification with His10–Rad9 on
nickel–NTA-agarose beads. UV-irradiated
(60 J/m2; +UV) or mock-treated (–UV)
extracts from the diploid strains indicated on
the right were incubated with nickel–NTA-
agarose beads. The beads were washed in a
buffer containing 20 mM imidazole and then
eluted with 250 mM imidazole. The fractions
were analysed by HA western blotting. FT,
flow-through; W1–3, washes 1–3; E1–4,
elutions 1–4. As a further negative control,
extracts from diploid cells containing
untagged Rad9 and HA3–Rad9 did not reveal
any HA3–Rad9 in the elution fractions (data
not shown).
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was abolished when His10–Rad9F+W was used. In the
absence of DNA damage, hypophosphorylated HA3–Rad9
weakly interacted with wild-type or mutant His10–Rad9,
showing that in this case the interaction was independent
of the aromatic residues. Together, these data suggest
that, although a fraction of Rad9 interacts with itself in
undamaged cells, perhaps through a non-BRCT domain,
after DNA damage an interaction between Rad9 BRCT
domains occurs with greater affinity. This DNA-damage-
dependent interaction requires the conserved aromatic
residues of the BRCT domain, mutation of which results
in a rad9∆ phenotype, suggesting that a BRCT-domain-
mediated oligomerization is required for Rad9 function. 
Interactions between BRCT domains of different proteins
have been demonstrated for XRCC1, which interacts
though its carboxy-terminal BRCT domain with the BRCT
domain of ligase III-α [11,13], and through its amino-termi-
nal BRCT domain with the BRCT domain of PARP [12].
Additionally, the amino-terminal BRCT domain of the S.
pombe Cut5/Rad4 protein interacts with Crb2, which also
contains a BRCT tandem motif in its carboxyl terminus
[11]. Our results are consistent with the finding that the
carboxy-terminal BRCT domain of XRCC1 homodimerizes
in the recently reported crystal structure [14]. The absence
of any identifiable interaction with other S. cerevisiae BRCT-
domain proteins (see Supplementary material) highlights
the specificity of the Rad9 BRCT–BRCT interaction, but it
does not exclude the possibility that this domain may also
interact with other proteins. 
The rad9 null phenotypes observed for the rad9 BRCT
mutants demonstrate that the BRCT domain is essential
for Rad9’s normal function. The Rad9–Rad9 interaction
occurred with a much greater affinity when Rad9 was
hyperphosphorylated and was inhibited by the BRCT
point mutations. Together, these data suggest that
oligomerization of Rad9 is regulated by DNA damage and
is required for the DNA-damage-checkpoint response.
Overexpression of the mutant proteins partially rescued
the rad9 null phenotype, perhaps overcoming by protein
dosage their failure to oligomerize. Hyperphosphorylated
forms of Rad9 also interact with the second forkhead-
homology-associated domain of Rad53 [5]. The Rad53-
binding domain of Rad9 is located upstream from the
BRCT domain [5]. It is likely that, after DNA damage, a
high-molecular-weight complex forms, at least transiently,
which contains phosphorylated Rad53, hyperphosphory-
lated Rad9 and perhaps other proteins. This complex may
be involved in sensing or processing DNA lesions and/or
in transducing the DNA-damage-checkpoint signal.
Our data may be relevant to other proteins with BRCT
domains, including the tumour-suppressor protein
BRCA1, which also contains tandem BRCT motifs in its
carboxyl terminus [2,3] and is hyperphosphorylated after
DNA damage in a manner similar to Rad9 [15]. In addi-
tion to numerous nonsense mutations leading to truncated
BRCA1, mutation of the conserved tryptophan of the
second BRCT motif of BRCA1 (W1708D) has been
reported in the BIC database (see www.nhgri.nih.gov/Intra-
mural_research/Lab_transfer/Bic). The phosphorylation
state of truncated or point-mutated BRCA1 proteins has
not been reported to date. 
Supplementary material
Additional details, including construction of mutant strains, plasmids for
two-hybrid analysis, GST precipitation analysis, production of diploid
strains expressing differentially tagged Rad9 proteins, nickel–agarose
chromatography, western analysis of overexpressed Rad9 and addition
two-hybrid data are published with this paper on the internet.
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Supplementary materials and methods
rad9 mutations
The YCpIF16-Rad9 construct, which we used to express wild-type
RAD9 under the control of a galactose-inducible promoter, has been
previously described [S1]. It was deleted or mutated as follows: the
carboxy-terminal truncation was achieved by removal of a 502 bp
HindIII fragment, resulting in a frameshift which created a stop codon
leading to a deletion of the carboxy-terminal 223 residues of Rad9. The
site-directed mutations were generated using the QuickChange Site-
Directed Mutagenesis Kit (Stratagene) and the primer pairs 5′-
CACTACACTGGAAATTGATAAGTGCATGCATTG-3′ and 5′-CAA-
TGCATGCACTTATCAATTTCCAGTGTAGTG-3′, for the C3868G
mutation that resulted in the F1104L substitution in BRCTa; 5′-CAC-
TGAATCTAAAGAATTGCTAATTCAGACAATAATTAACG-3′ and 5′-
CGTTAATTATTGTCTGAATTAGCAATTCTTTAGATTCAGTG-3′, for
the G4396T mutation that resulted in the W1280L substitution in
BRCTb. Mutated bases are underlined. 
Replacement of the endogenous RAD9 with the rad9 mutations
The 1230 bp 3′ regions of the wild-type or mutated rad9 genes were
amplified using primers 5′-CGCGGATCCGCTAAAAGAGCGAAG ATC-
A-3′ and 5′-CGCGGATCCTCATCTAACCTCAGAAATAG-3′, and the
resulting fragments were cloned into the BamHI site of the pRS303 inte-
gration vector from which the SacI site had been destroyed by SacI diges-
tion, filling in with Pfu polymerase and re-ligation. The constructs were
integrated into the RAD9 locus of the W303-1a strain after SacI lineariza-
tion, leading to replacement of the last 1048 nucleotides of the RAD9
gene. Correct integration was checked for all mutants by genomic PCR .
Two-hybrid system
A 978 bp 3′ terminal fragment of the RAD9 gene encoding the BRCT
motifs was amplified between the primers 5′-CATGCCATGGGTGAA-
ATCAGAACAGGG-3′ and 5'-CGCGGATCCTCATCTAACCTCAGA-
AATAG-3′ and cloned between the NcoI and BamHI sites of the
pAS1-CYH2 vector in order to produce the BRCT–BD bait fusion
protein. This construct was point-mutated as described above in order
to produce the mutant fusion protein BRCTF+W–BD. The wild-type
BRCT-domain-encoding fragment and the full-length RAD9 gene were
cloned in frame in the pACT2 vector (Clontech), as well as the other
BRCT-protein-encoding S. cerevisiae genes (Table 1), and the RAD53
and YBR274w genes. All PCR reactions were performed using the Pfu
high-fidelity DNA polymerase (Stratagene) and the resulting fragments
were cloned into the pACT2 vector.
GST binding assay
The wild-type and mutated BRCT 978 bp 3′ terminal fragments of the
RAD9 gene used for the two-hybrid test were subcloned into the
pRP261 vector (a pGEX3 derived vector). The GST–BRCT and
GST–BRCTF+W fusion proteins were produced in bacteria by 2 h
growth in 0.4 mM IPTG at 30°C. The wild-type 978 bp 3′ terminal frag-
ment of RAD9 was also cloned in the pET21a vector (Novagen) in
frame with the T7 tag sequence in order to produce the amino-terminal
T7-tagged BRCT fusion protein. Bacterially expressed extracts were
incubated for 4 h at 4°C with the GST fusion proteins bound to glu-
tathione–Sepharose beads (Pharmacia). After extensive washes under
high-stringency conditions (the wash buffer contained 0.6 M NaCl,
50 mM Tris pH 7.5, 10% glycerol, 0.5% Tween20, 8 mM β-mercap-
toethanol, 170 µg/ml phenylmethylsulphonyl fluoride (PMSF), 1 µg/ml
leupeptin, 1 µg/ml pepstatin A, 1 µg/ml antipain, 330 µg/ml benzami-
dine and 50 mM NaF), the beads were boiled in Laemmli buffer and the
proteins were revealed by western blotting using the T7 tag mono-
clonal antibody (Novagen). Yeast protein extracts from UV-irradiated or
mock-treated wild-type cells were incubated for 4 h at 4°C with the
fusion proteins bound to glutathione–Sepharose beads. After extensive
Supplementary material
Figure S1
Western analysis of the levels of overexpression of wild-type and
mutant Rad9 proteins. 10 µg wild-type W303 extracts were compared
to 0.1 µg (1/100 dilution) extracts from the mutant strains and controls.
Note that overexpression of Rad9 led to a slight decrease in its
mobility relative to endogenous Rad9, possibly due to limiting Rad9-
directed phosphatase activities.
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Table S1
Two-hybrid screening of the S. cerevisiae BRCT proteins. 
Rad9 BRCT Negative controls
Rad9 + –
Dpb11 – –
Lig4 – –
Rap1 – –
Rfc1 +/– +/–
Fcp1 + +
Yhv4 – –
YGR103w – –
Chs5 – –
Rev1 nd nd
The ten S. cerevisiae proteins identified from the yeast genome that
contain one or several BRCT motifs in their amino-acid sequences are
shown [2,3]. Nine of the ten were tested using the two-hybrid system
for an interaction with the Rad9 BRCT domain. A specific interaction
with Rad9 itself (see Figure 3a) but not with the other proteins listed
was demonstrated. As negative controls, the interaction of each
protein with p53 and laminin was measured. nd, not determined.
washes in a wash buffer containing 25 mM Hepes pH 7.6, 10% glyc-
erol, 0.2 M NaCl, 0.5% Tween20, 8 mM β-mercaptoethanol, 170 µg/ml
PMSF, 1 µg/ml leupeptin, 1 µg/ml pepstatin A, 1 µg/ml antipain,
330 µg/ml benzamidine, 50 mM NaF, 50 mM β-glycerophosphate,
10 mM NaVO3 and 50 mM EGTA, the beads were boiled in Laemmli
buffer and the proteins were revealed by Rad9 western blotting. 
Production of diploid strains expressing differentially tagged
Rad9 proteins
The His10–RAD9 (Mata) and His10–rad9F+W strains (Mata) were
obtained by integration of a His10 tag between the promoter and start
codon of the RAD9 gene in the wild-type (W303-1a) and rad9F+W
strains, respectively. Similarly the HA3–rad9 strain was obtained by inte-
gration of a HA3 tag between the promoter and start codon of the RAD9
gene in the W303-1b (Matα) strain. Integration of these construct into the
yeast genome maintained normal levels of expression from the endoge-
nous RAD9 promoter. These strains were mated to obtain the diploid
strains His10–RAD9/HA3–RAD9 and His10–rad9F+W/HA3–RAD9. All the
strains were checked by PCR and western blot. 
Nickel–agarose chromatography 
Protein extracts from the irradiated (60 J/m2) and mock-treated diploid
cells were purified on nickel–NTA superflow agarose beads (Qiagen)
as previously described [S2], and the fractions were analyzed by anti-
HA (12CA5) western blotting.
UV irradiation, survival assays, checkpoint-delay-phenotype assays, and
Rad9/Rad53 western blotting were performed as previously described
[S1,S2].
Strains
With the exception of standard strains used for two-hybrid analysis, all
strains were in the W303 background.
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